Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
American Journal of Clinical Dermatology
|
May 9, 2022
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents
Stergios J Moschos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2022
War against NRAS-Mutant Melanoma Using Targeted Therapies Remains Challenging
Stergios J Moschos
Surgical Oncology Clinics of North America
|
March 15, 2015
Targeted therapies in melanoma
Stergios J Moschos, Ramya Pinnamaneni
Expert Opinion on Biological Therapy
|
April 17, 2009
The use of endostatin in the treatment of solid tumors
Michalis V Karamouzis, Stergios J Moschos
Oncology
|
November 6, 2002
The role of the IGF system in cancer: from basic to clinical studies and clinical applications
Stergios J Moschos, Christos S Mantzoros
Journal of Molecular Histology
|
June 8, 2006
Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis
Stergios J Moschos, Yin-Yuan Mo
Expert Opinion on Therapeutic Targets
|
November 23, 2005
Targeting Ubc9 for cancer therapy
Yin-Yuan Mo, Stergios J Moschos
Genes & Cancer
|
July 23, 2011
Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma
Xiaolei Wang, Stergios J Moschos, Dorothea Becker
Cancer Chemotherapy and Biological Response Modifiers
|
August 23, 2005
Melanoma
Stergios J Moschos, Panagiotis A Konstantinopoulos, John M Kirkwood
Journal of the National Cancer Institute
|
June 12, 2008
Resolving "kinks" of chemotherapy in melanoma
Stergios J Moschos, Preet M Chaudhary, John M Kirkwood
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
American Journal of Clinical Dermatology
|
May 9, 2022
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents
Stergios J Moschos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2022
War against NRAS-Mutant Melanoma Using Targeted Therapies Remains Challenging
Stergios J Moschos
Surgical Oncology Clinics of North America
|
March 15, 2015
Targeted therapies in melanoma
Stergios J Moschos, Ramya Pinnamaneni
Expert Opinion on Biological Therapy
|
April 17, 2009
The use of endostatin in the treatment of solid tumors
Michalis V Karamouzis, Stergios J Moschos
Oncology
|
November 6, 2002
The role of the IGF system in cancer: from basic to clinical studies and clinical applications
Stergios J Moschos, Christos S Mantzoros
Journal of Molecular Histology
|
June 8, 2006
Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis
Stergios J Moschos, Yin-Yuan Mo
Expert Opinion on Therapeutic Targets
|
November 23, 2005
Targeting Ubc9 for cancer therapy
Yin-Yuan Mo, Stergios J Moschos
Genes & Cancer
|
July 23, 2011
Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma
Xiaolei Wang, Stergios J Moschos, Dorothea Becker
Cancer Chemotherapy and Biological Response Modifiers
|
August 23, 2005
Melanoma
Stergios J Moschos, Panagiotis A Konstantinopoulos, John M Kirkwood
Journal of the National Cancer Institute
|
June 12, 2008
Resolving "kinks" of chemotherapy in melanoma
Stergios J Moschos, Preet M Chaudhary, John M Kirkwood
Page
of 8